Header Logo

Connection

Ian Sanne to Pyrazinamide

Back to Details
This is a "connection" page, showing publications Ian Sanne has written about Pyrazinamide.
Ian Sanne
Connection Strength
0,034
Pyrazinamide
  1. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Lancet Infect Dis. 2017 01; 17(1):39-49.
    View in: PubMed
    Score: 0,034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.